Omega-3: The good oil

Nutrition Bulletin

Volumn 42, Issue 2, 2017, Pages 132-140

  Calder, P C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85018432258     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/nbu.12261     Document Type: Article

References (49)

1. Al MDM, van Houwelingen AC, Kester ADM et al. (1995) Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. British Journal of Nutrition 74: 55–68.
2. Anonymous (no authors listed) (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet 354: 447–55.
3. Araya J, Rodrigo R, Videla LA et al. (2004) Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science 106: 635–43.
4. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. American Journal of Clinical Nutrition 83: 1467S–76S.
5. Baker EJ, Miles EA, Burdge GC et al. (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Progress in Lipid Research 64: 30–56.
6. Bannenberg G & Serhan CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochimica et Biophysica Acta 1801: 1260–73.
7. Bisgaard H, Stokholm J, Chawes BL et al. (2016) Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring. New England Journal of Medicine 375: 2530–9.
8. Blasbalg TL, Hibbeln JR, Ramsden CE et al. (2011) Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. American Journal of Clinical Nutrition 93: 950–62.
9. British Nutrition Foundation (2013) Nutrition and Development: Short and Long Term Consequences for Health. Wiley-Blackwell: Oxford.
10. Browning LM, Walker CG, Mander AP et al. (2012) Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. American Journal of Clinical Nutrition 96: 748–58.
11. Calder PC (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clinical Science 107: 1–11.
12. Calder PC (2012) Mechanisms of action of (n-3) fatty acids. Journal of Nutrition 142: 592S–9S.
13. Calder PC (2014) Very long chain omega-3 (n-3) fatty acids and human health. European Journal of Lipid Science and Technology 116: 1280–300.
14. Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta 1851: 469–84.
15. Calder PC (2016) Docosahexaenoic acid. Annals of Nutrition and Metabolism 69(Suppl. 1): 8–21.
16. Calder PC, Kremmyda LS, Vlachava M et al. (2010) Is there a role for fatty acids in early life programming of the immune system? Proceedings of the Nutrition Society 69: 373–80.
17. Cawood AL, Ding R, Napper FL et al. (2010) Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 212: 252–9.
18. Chowdhury R, Warnakula S, Kunutsor S et al. (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of Internal Medicine 160: 398–406.
19. Dalli J, Colas RA & Serhan CN (2013) Novel n-3 immunoresolvents: structures and roles. Scientific Reports 3: 1940.
20. Del Gobbo LC, Imamura F, Aslibekyan S et al. (2016) ω-3 Polyunsaturated fatty acid biomarkers and coronary heart disease - pooling project of 19 cohort studies. JAMA Internal Medicine 176: 1155–66.
21. Elizondo A, Araya J, Rodrigo R et al. (2007) Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity 15: 24–31.
22. European Food Safety Authority (2010) Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids and cholesterol. EFSA Journal 8: 1461.
23. Food and Agricultural Organisation of the United Nations (2010) Fat and Fatty Acids in Human Nutrition: Report of an Expert Consultation. Food and Agricultural Organisation of the United Nations: Rome.
24. Harris WS, Sands SA, Windsor SL et al. (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 110: 1645–9.
25. Healy DA, Wallace FA, Miles EA et al. (2000) The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35: 763–8.
26. Hillier K, Jewell R, Dorrell L et al. (1991) Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32: 1151–5.
27. Howe P, Meyer B, Record S et al. (2006) Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 22: 47–53.
28. Katan MB, Deslypere JP, van Birgelen APJM et al. (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes and adipose tissue: an 18 month controlled study. Journal of Lipid Research 38: 2012–22.
29. Kaur G, Cameron-Smith D, Garg M et al. (2011) Docosapentaenoic acid (22:5n-3): a review of its biological effects. Progress in Lipid Research 50: 28–34.
30. Koletzko B, Cetin I & Brenna JT (2007) Dietary fat intakes for pregnant and lactating women. British Journal of Nutrition 98: 873–7.
31. Kremmyda L-S, Vlachava M, Noakes PS et al. (2011) Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 Fatty acids: a systematic review. Clinical Reviews in Allergy and Immunology 41: 36–66.
32. Makrides M, Neumann MA, Byard RW et al. (1994) Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. American Journal of Clinical Nutrition 60: 189–94.
33. McGlory C, Galloway SD, Hamilton DL et al. (2014) Temporal changes in human skeletal muscle and blood lipid composition with fish oil supplementation. Prostaglandins Leukotrienes and Essential Fatty Acids 90: 199–206.
34. Metcalf RG, James MJ, Gibson RA et al. (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans. American Journal of Clinical Nutrition 85: 1222–8.
35. Meyer BJ, Mann NJ, Lewis JL et al. (2003) Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 38: 391–8.
36. Miles EA, Noakes PS, Kremmyda LS et al. (2011) The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition 94: 1986S–92S.
37. Noakes PS, Vlachava M, Kremmyda LS et al. (2012) Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition 95: 395–404.
38. Otto SJ, Houwelingen AC, Antal M et al. (1997) Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. European Journal of Clinical Nutrition 51: 232–42.
39. Plutzky J (1999) Atherosclerotic plaque rupture: emerging insights and opportunities. American Journal of Cardiology 84: 15J–20J.
40. Rahmawaty S, Charlton K, Lyons-Wall P et al. (2013) Dietary intake and food sources of EPA, DPA and DHA in Australian children. Lipids 48: 869–77.
41. Safarinejad MR (2011) Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study. Andrologia 43: 38–47.
42. Saravanan P, Davidson NC, Schmidt EB et al. (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376: 540–50.
43. SACN/COT (Scientific Advisory Committee on Nutrition/Committee on Toxicity) (2004) Advice on Fish Consumption: Benefits and Risks. TSO: London.
44. Sioen I, van Lieshout L, Eilander A et al. (2017) Systematic review on n-3 and n-6 polyunsaturated fatty acid intake in European countries in light of the current recommendations - focus on specific population groups. Annals of Nutrition and Metabolism 70: 39–50.
45. Skinner ER, Watt C, Besson JA et al. (1993) Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116: 717–25.
46. Smith GI, Atherton P, Reeds DN et al. (2011) Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clinical Science 121: 267–78.
47. Stary HC, Chander AB & Dinsmore RE (1995) The definition of advanced type of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92: 1355–74.
48. Thies F, Garry JMC, Yaqoob P et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. The Lancet 361: 477–85.
49. Urwin HJ, Miles EA, Noakes PS et al. (2012) Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition 142: 1603–10.